Ascenta Capital, Biotech Venture Capital & Drug Development
Translating Science into Medicines
Ascenta Capital was born to help innovative companies as they grow from their scientific foundations to advance the clinical development of meaningful medicines for patients. We make concentrated investments and work in collaboration to support our management teams with our strategic and operational experience.
01.
Deep Scientific Insight
We make concentrated investments and work in collaboration to support our manag
02.
Patient-Centered Approach
We invest in innovations that have the power to make a meaningful difference in patients’ lives, keeping patient needs at the heart of every decision.
03.
Strategic Growth Support
Beyond capital, we provide strategic guidance, connections, and resources to help our partners scale effectively and sustainably.
$335 Million
Assets Under Management
$15-30 Million
Biotech Investments
Our Strategy
Phase 1 and 2
We partner with companies that have development candidates, translating their preclinical science into early human safety and efficiency data.
Platforms
We believe there lies opportunity in multi-medicine platforms. Complex questions of growth, strategy and value creation are front and center, and offer asymmetric upside
Our Values
Originate Conviction
Act Decisively
Be Collaborative
Stay Nimble
Patients are waiting. Biopharma’s essence is delivering innovative medicines to patients with major unmet needs. Management, scientists, clinical investigators, and investors all together strive towards that shared goal. Today, the biotech renaissance is in full swing.
The global convergence of biological and chemical insights, life science technology, data analytics, talent and capital is unprecedented.
This is the time to invest
The global convergence of biological and chemical insights, life science technology, data analytics, talent, and capital is unprecedented.